Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy and safety of oral valganciclovir
versus intravenous ganciclovir in patients following allogenic stem cell transplantation.